Ad is loading...
ADNRX vs FSMAX
ADNRX vs FSMAX Comparison
Open Charts ADNRX vs FSMAX
American Beacon ARK Transfmt Innov R6
Price$13.23
Change+$0.51 (+4.01%)
VolumeN/A
Net Assets143.97M
Fidelity Extended Market Index
Price$79.49
Change+$1.44 (+1.84%)
VolumeN/A
Net Assets36.55B
ADNRX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. FSMAX commentary
Apr 25, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and FSMAX is a StrongBuy.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 36.5B vs. ADNRX (144M). FSMAX pays higher dividends than ADNRX: FSMAX (0.53) vs ADNRX (0.00). ADNRX was incepted earlier than FSMAX: ADNRX (4 years) vs FSMAX (14 years). ADNRX (1.13) is less costly to investors than FSMAX (0.04). ADNRX is a more actively managed with annual turnover of: 38.00 vs. FSMAX (9.00). ADNRX (0) and FSMAX (0) have matching initial minimum investment requirements. ADNRX annual gain was more profitable for investors over the last year : 5.91 vs. FSMAX (-1.02).
| ADNRX | FSMAX | ADNRX / FSMAX | |
| Total Expense Ratio | 1.00 | 0.04 | 2,857% |
| Annual Report Gross Expense Ratio | 1.13 | 0.04 | 3,229% |
| Fund Existence | 4 years | 14 years | - |
| Gain YTD | -18.409 | -14.118 | 130% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 144M | 36.5B | 0% |
| Annual Yield % from dividends | 0.00 | 0.53 | - |
| Returns for 1 year | 5.91 | -1.02 | -577% |
| Returns for 3 years | -17.72 | 10.08 | -176% |
| Returns for 5 years | N/A | 63.03 | - |
| Returns for 10 years | N/A | 45.70 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers